SENATE FILE 2312
Introduced
Manufacturers and distributors of 340B drugs
✓
Introduced
Passed subcommittee
Passed committee
Passed one chamber
Passed both chambers
Signed by Governor
Lobbyist declarations
19 declarations filed on this bill
Related legislation
Part of a group of 3 related bills
| Date | Chamber | Action |
|---|---|---|
| Feb 12, 2026 | Senate | Introduced, referred to Commerce. S.J. 272. |
| Feb 18, 2026 | Senate | Subcommittee: Sweeney, Knox, and Warme. S.J. 314. |
No floor votes on this bill yet.
| Client | Declaration | Last updated |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Against | Feb 12, 2026 |
| Bristol Myers Squibb Co. | Against | Feb 16, 2026 |
| Eli Lilly & Co. | Against | Feb 13, 2026 |
| Genentech, Inc., A Member of the Roche Group | Against | Feb 13, 2026 |
| Iowa Biotechnology Association | Against | Feb 12, 2026 |
| Merck Sharp & Dohme LLC | Against | Feb 13, 2026 |
| Novartis Services, Inc. | Against | Feb 13, 2026 |
| Novo Nordisk | Against | Feb 13, 2026 |
| Pharmaceutical Research and Manufacturers of America (PhRMA) | Against | Feb 12, 2026 |
| Iowa Hospital Association | For | Feb 13, 2026 |
| Iowa Integrated Health Planning and Advisory Council | For | Feb 13, 2026 |
| Iowa Medical Society | For | Feb 16, 2026 |
| Iowa Pharmacy Association | For | Feb 13, 2026 |
| Iowa Primary Care Association | For | Mar 4, 2026 |
| Healthcare Distribution Alliance c/o MultiState Associates LLC | Undecided | Feb 12, 2026 |
| Iowa Board of Regents | Undecided | Feb 13, 2026 |
| Iowa Department of Inspections, Appeals, and Licensing | Undecided | Feb 13, 2026 |
| Iowa Insurance Division | Undecided | Feb 13, 2026 |
| Wellmark, Inc. | Undecided | Feb 13, 2026 |
No hearings or meetings scheduled for this bill.